Document ID: FDA-2019-N-0803-0003
Agency: fda
Document Type: Notice
Title: Advisory Committee; Technical Electronic Product Radiation Safety Standards Committee; Renewal
Posted Date: 2023-01-24T05:00Z

[Federal Register Volume 88, Number 15 (Tuesday, January 24, 2023)]
[Notices]
[Page 4190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01219]

[[Page 4190]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2019-N-0803]

Advisory Committee; Technical Electronic Product Radiation Safety 
Standards Committee; Renewal

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; renewal of Federal advisory committee.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
renewal of the Technical Electronic Product Radiation Safety Standards 
Committee by the Commissioner of Food and Drugs (the Commissioner). The 
Commissioner has determined that it is in the public interest to renew 
the Technical Electronic Product Radiation Safety Standards Committee 
for an additional 2 years beyond the charter expiration date. The new 
charter will be in effect until December 24, 2024.

DATES: Authority for the Technical Electronic Product Radiation Safety 
Standards Committee will expire on December 24, 2024, unless the 
Commissioner formally determines that renewal is in the public 
interest.

FOR FURTHER INFORMATION CONTACT: Akinola Awojope, Center for Devices 
and Radiological Health, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 66, Rm. 5216, Silver Spring, MD 20993-0002, 301-
636-0512, [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to 41 CFR 102-3.65 and approval by 
the Department of Health and Human Services and by the General Services 
Administration, FDA is announcing the renewal of the Technical 
Electronic Product Radiation Safety Standards Committee. The committee 
is a non-discretionary Federal advisory committee established to 
provide advice and consultation to the Commissioner. The Commissioner 
is charged with the administration of the Radiation Control for Health 
and Safety Act of 1968. This Act creates the Technical Electronic 
Product Radiation Safety Standards Committee and requires the 
Commissioner to consult with the Committee before prescribing standards 
for radiation emissions from electronic products. This Committee 
provides advice and consultation to the Commissioner on the technical 
feasibility, reasonableness, and practicability of performance 
standards for electronic products to control the emission of radiation 
from such products, and may recommend electronic product radiation 
safety standards to the Commissioner for consideration.
    The Committee shall consist of 15 voting members including the 
Chair. Members and the Chair are selected by the Commissioner or 
designee from among authorities knowledgeable in the fields of science 
or engineering applicable to electronic product radiation safety. 
Members will be invited to serve for overlapping terms of up to 4 
years. Terms of more than 2 years are contingent upon the renewal of 
the Committee by appropriate action prior to its expiration. Voting 
members will include five members selected from governmental agencies, 
including State and Federal Governments, five members from the affected 
industries, and five members from the general public, of which at least 
one shall be a representative of organized labor. A quorum shall 
consist of 10 members, of which at least 3 shall be from the general 
public, 3 from the government agencies, and 3 from the affected 
industries.
    Further information regarding the most recent charter and other 
information can be found at https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Radiation-EmittingProducts/TechnicalElectronicProductRadiationSafetyStandardsCommittee/default.htm 
or by contacting the Designated Federal Officer (see FOR FURTHER 
INFORMATION CONTACT). In light of the fact that no change has been made 
to the committee name or description of duties, no amendment will be 
made to 21 CFR 14.100.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app.). For general information related to FDA advisory 
committees, please visit us at http://www.fda.gov/AdvisoryCommittees/default.htm.

    Dated: January 18, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-01219 Filed 1-23-23; 8:45 am]
BILLING CODE 4164-01-P